Comparison between Evoq Remedies IPO and Swaraj Suiting IPO.
Evoq Remedies IPO is a SME Fixed Price IPO proposed to list at BSE SME while Swaraj Suiting IPO is a SME Fixed Price proposed to list at NSE SME.
| Evoq Remedies IPO | Swaraj Suiting IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Swastika Investmart Ltd. | Finshore Management Services Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Sunflower Broking Pvt.Ltd. | Nikunj Stock Brokers Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Evoq Remedies IPO is up to ₹9.23 Cr whereas the issue size of the Swaraj Suiting IPO is up to ₹10.15 Cr. The final issue price of Evoq Remedies IPO is ₹27.00 per share and of Swaraj Suiting IPO is ₹56.00 per share.
| Evoq Remedies IPO | Swaraj Suiting IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹27.00 per share | ₹56.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 4000 shares | 2000 shares |
| Fresh Issue Size | 34,20,000 shares | 18,12,000 shares |
| Fresh Issue Size (Amount) | up to ₹9.23 Cr | up to ₹10.15 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 34,20,000 shares | 18,12,000 shares |
| Issue Size Total (Amount) | up to ₹9.23 Cr | up to ₹10.15 Cr |
Evoq Remedies IPO opens on Mar 17, 2022, while Swaraj Suiting IPO opens on Mar 15, 2022. The closing date of Evoq Remedies IPO and Swaraj Suiting IPO is Mar 22, 2022, and Mar 17, 2022, respectively.
| Evoq Remedies IPO | Swaraj Suiting IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Mar 17, 2022 | Mar 15, 2022 |
| Issue Close | Mar 22, 2022 | Mar 17, 2022 |
| Basis Of Allotment (Tentative) | Mar 25, 2022 | Mar 23, 2022 |
| Initiation of Refunds (Tentative) | Mar 28, 2022 | Mar 24, 2022 |
| Credit of Share (Tentative) | Mar 29, 2022 | Mar 25, 2022 |
| Listing date (Tentative) | Mar 30, 2022 | Mar 28, 2022 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Evoq Remedies IPO P/E ratio is 33.75, as compared to Swaraj Suiting IPO P/E ratio of 10.55.
| Evoq Remedies IPO | Swaraj Suiting IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 99.99 | 99.74 | ||||
| Promoter Shareholding (Post-Issue) | 73.53 | 73.31 | ||||
| P/E Ratio | 33.75 | 10.55 | ||||
| Market Cap | ₹36.72 Cr. | ₹40.32 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ₹10.05 | ₹11.99 | ||||
| RoNW | 96.94 | 6.99 |
In the Evoq Remedies IPO Retail Individual Investors (RII) are offered 17,10,000 shares while in Swaraj Suiting IPO retail investors are offered 17,10,000 shares. Qualified Institutional Buyers (QIB) are offered in Evoq Remedies IPO and in Swaraj Suiting IPO.
| Evoq Remedies IPO | Swaraj Suiting IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 1,80,000 shares | 96,000 shares |
| QIB | ||
| NII | 17,10,000 shares | 9,04,000 shares |
| RII | 17,10,000 shares | 9,08,000 shares |
| Employee | ||
| Others | ||
| Total | 34,20,000 shares | 18,12,000 shares |
Evoq Remedies IPO subscribed 1.67x in total, whereas Swaraj Suiting IPO subscribed 12.13x.
| Evoq Remedies IPO | Swaraj Suiting IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 0.30x | 13.81x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 3.03x | 10.46x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.67x | 12.13x |
